The Department of Justice will host two unusual meetings for congressional leaders Thursday as Republicans demand classified records involving the use of a confidential FBI informant during the early days of the Russia and investigation.

President Trump on Thursday signed bipartisan legislation rolling back some of the Dodd-Frank financial rules put in place after the 2008 financial crisis, touting another victory for his deregulatory agenda.

But the bill fell well short of his campaign call to dismantle the 2010 Dodd-Frank law,...

The Internal Revenue Service is preparing to block attempts by California and other states to help their residents avoid a new limit on the deductibility of state and local taxes included in the Republican tax overhaul.

The IRS and the Treasury Department said Wednesday they would issue proposed...

13 members of Congress have written to FCC Chairman Ajit Pai criticizing his "repeated evasive responses to our inquiries" and "outright refusal to respond to some of the members of this Committee." Unsatisfied with the answers or evasions he has offered to date, they reiterate questions related to net neutrality and other issues that they've sent over the past months.

President Donald Trump is a teetotaler. He has never had a drink, he says, because he saw what booze did to his beloved older brother Freddy, an alcoholic who died at the age of 43. As far back as 1999, when he was first contemplating a run for the White House, Trump told Larry King […]

A state rule aimed at protecting drinking water sources from nitrate contamination originating from nitrogen fertilizer could be delayed for a year or more in a dust-up over agriculture policy at the Capitol.

Speaking in front of EU lawmakers today Facebook’s founder Mark Zuckerberg namechecked the GDPR’s core principles of “control, transparency and accountability” — claiming his company will deliver on all that, come Friday, when a new European Union data protection framework, GDPR, starts being applied, finally with penalties worth the enforcement. However there was little transparency […]

The measure would let people with life-threatening illnesses bypass the Food and Drug Administration to get experimental drugs. The president is expected to sign it, ending a long battle over access to unapproved therapies.